Cargando…
Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine
A 65-year-old man with entero-Behçet's disease (BD) being treated with mesalazine was presented to our hospital complaining of dyspnea. Computed tomography (CT) of the chest showed ground-glass opacities and he was initially diagnosed with mesalazine-induced interstitial pneumonitis (IP). Besid...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939210/ https://www.ncbi.nlm.nih.gov/pubmed/27429824 http://dx.doi.org/10.1155/2016/5636489 |
_version_ | 1782441973878095872 |
---|---|
author | Nakamura, Akihiro Miyamura, Tomoya Wu, Brian Suematsu, Eiichi |
author_facet | Nakamura, Akihiro Miyamura, Tomoya Wu, Brian Suematsu, Eiichi |
author_sort | Nakamura, Akihiro |
collection | PubMed |
description | A 65-year-old man with entero-Behçet's disease (BD) being treated with mesalazine was presented to our hospital complaining of dyspnea. Computed tomography (CT) of the chest showed ground-glass opacities and he was initially diagnosed with mesalazine-induced interstitial pneumonitis (IP). Besides the discontinuation of mesalazine, a high dose of oral prednisolone was administered and the patient seemed to recover. However, four months later, dyspnea recurred and repeated CT revealed more extensive pulmonary infiltration despite steroid therapy. After the exclusion of infections, we suspected either a recurrence of mesalazine-induced IP or BD-related IP as a clinical manifestation of BD. The patient was treated with intravenous methylprednisolone and cyclophosphamide, followed by orally administered azathioprine, based on the assumption of underlying vasculitis. Thereafter, his condition improved. BD-related IP is an extremely rare condition with limited reports in the literature. Mesalazine-induced IP is also uncommon but the prognosis is generally good after discontinuation of mesalazine with or without steroid therapy. We discuss an extremely rare case, especially focusing on BD-related IP and mesalazine-induced IP as a potential cause of recurrent IP in a patient with entero-BD. |
format | Online Article Text |
id | pubmed-4939210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-49392102016-07-17 Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine Nakamura, Akihiro Miyamura, Tomoya Wu, Brian Suematsu, Eiichi Case Rep Rheumatol Case Report A 65-year-old man with entero-Behçet's disease (BD) being treated with mesalazine was presented to our hospital complaining of dyspnea. Computed tomography (CT) of the chest showed ground-glass opacities and he was initially diagnosed with mesalazine-induced interstitial pneumonitis (IP). Besides the discontinuation of mesalazine, a high dose of oral prednisolone was administered and the patient seemed to recover. However, four months later, dyspnea recurred and repeated CT revealed more extensive pulmonary infiltration despite steroid therapy. After the exclusion of infections, we suspected either a recurrence of mesalazine-induced IP or BD-related IP as a clinical manifestation of BD. The patient was treated with intravenous methylprednisolone and cyclophosphamide, followed by orally administered azathioprine, based on the assumption of underlying vasculitis. Thereafter, his condition improved. BD-related IP is an extremely rare condition with limited reports in the literature. Mesalazine-induced IP is also uncommon but the prognosis is generally good after discontinuation of mesalazine with or without steroid therapy. We discuss an extremely rare case, especially focusing on BD-related IP and mesalazine-induced IP as a potential cause of recurrent IP in a patient with entero-BD. Hindawi Publishing Corporation 2016 2016-06-26 /pmc/articles/PMC4939210/ /pubmed/27429824 http://dx.doi.org/10.1155/2016/5636489 Text en Copyright © 2016 Akihiro Nakamura et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Nakamura, Akihiro Miyamura, Tomoya Wu, Brian Suematsu, Eiichi Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine |
title | Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine |
title_full | Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine |
title_fullStr | Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine |
title_full_unstemmed | Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine |
title_short | Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine |
title_sort | recurrent interstitial pneumonitis in a patient with entero-behçet's disease initially treated with mesalazine |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939210/ https://www.ncbi.nlm.nih.gov/pubmed/27429824 http://dx.doi.org/10.1155/2016/5636489 |
work_keys_str_mv | AT nakamuraakihiro recurrentinterstitialpneumonitisinapatientwithenterobehcetsdiseaseinitiallytreatedwithmesalazine AT miyamuratomoya recurrentinterstitialpneumonitisinapatientwithenterobehcetsdiseaseinitiallytreatedwithmesalazine AT wubrian recurrentinterstitialpneumonitisinapatientwithenterobehcetsdiseaseinitiallytreatedwithmesalazine AT suematsueiichi recurrentinterstitialpneumonitisinapatientwithenterobehcetsdiseaseinitiallytreatedwithmesalazine |